1
|
Draugelis S, Zurek K, Brown E, Ryan M, Chuang C, Sutherland P. Electronic health records system as a catalyst for inter-institutional
collaboration in international medical relief work. Ann Glob Health 2016. [DOI: 10.1016/j.aogh.2016.04.153] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
2
|
Centenera M, Treloar J, Hanson A, Sutherland P, Tilley W, Butler L. 61 Evaluation of the synthetic heat shock protein 90 inhibitors NVP-AUY922 and NVP-HSP990 in human prostate cancer tissue. EJC Suppl 2010. [DOI: 10.1016/s1359-6349(10)71766-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022] Open
|
3
|
Ludbrook G, Sutherland P. Erroneous pulse oximetry readings during robotic prostatectomy. Anaesth Intensive Care 2007; 35:144-5. [PMID: 17323688] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/14/2023]
|
4
|
Arnlöv J, Evans JC, Benjamin EJ, Larson MG, Levy D, Sutherland P, Siwik DA, Wang TJ, Colucci WS, Vasan RS. Clinical and echocardiographic correlates of plasma osteopontin in the community: the Framingham Heart Study. Heart 2006; 92:1514-5. [PMID: 16973806 PMCID: PMC1861062 DOI: 10.1136/hrt.2005.081406] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
|
5
|
Borg M, Sutherland P, Stapleton A, Bolt J, Steele D, Landers B, Porter A, Buxton S, Heilbornn C, Wong HZ. Outcome of post-prostatectomy radiotherapy in one institution. Australas Radiol 2006; 50:475-80. [PMID: 16981946 DOI: 10.1111/j.1440-1673.2006.01629.x] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
We present a retrospective study to evaluate the outcome of postoperative radiotherapy for biochemical or clinical recurrent prostate cancer. Twenty-six patients (median age 60 years) underwent radiotherapy after radical prostatectomy between January 1997 and January 2004. Seven patients received adjuvant radiotherapy and 19 received salvage radiotherapy. The median prostate-specific antigen at diagnosis was 8.6 (0.9-89) and most (23 patients) presented with T(3)N(0) disease. The median follow up was 19.5 months (5-84 months). All patients received a dose of 61.2 Gy at 1.8 Gy per fraction, 20 initially receiving 45 Gy to the lesser pelvis. The median dose to the bladder, rectum and left femoral head were 55.6, 57.5 and 33.8 Gy, respectively. All patients were managed radiotherapeutically by the first author. Twenty-four patients are alive. Two patients have died, one from oesophageal cancer and the second from metastatic prostate cancer. Two other patients also developed metastatic disease. Four asymptomatic patients with a rising prostate-specific antigen are under observation. None of the 26 patients has developed a local recurrence. Seven patients have developed grade 1 late bowel effects and three a grade 2 late effect. Eight patients suffer from grade 1 late genitourinary effects and two from grade 2 effects. One patient developed impotence, whereas 23 patients were rendered impotent postoperatively. There were no grade 3/4 late effects. Postoperative radiotherapy is well tolerated and provides effective local control.
Collapse
Affiliation(s)
- M Borg
- Department of Radiation Oncology, Royal Adelaide Hospital, Adelaide, SA, Australia.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
6
|
Mardi A, Rahimi G, Amani M, Mashoufi M, Kheirkhah M, Ghaffari NM, Pierovi T, Soleimani RJ, Vanlioglu F, Karaman Y, Bingol B, Tavmergen E, Akdogan A, Akman A, Levi R, Tavmergen GEN, Ates U, Seyhan A, Atmaca U, Ortakuz S, Ata B, Akar S, Usta T, Özdemir B, Sidal B, Yoldemir T, Gee A, Sutherland P, Bowman M, Fraser IS, Haydardedeoglu B, Bagis T, Kilicdag EB, Simsek E, Aslan E, Zeyneloglu HB, Kahyaoglu S, Turgay I, Ertas E, Yilmaz B, Var T, Batioglu S, Muftuoglu K, Tekcan C, Naki MM, Uysal A, Güzin K, Yücel N, Kanadikirik F, Kelekci S, Savan K, Kalyoncu S, Gokturk U, Oral H, Mollamahmutoglu L, Ertas IE, Mollamahmutoglu L, Kahveci S, Dogan M, Mollamahmutoglu L, Isik A, Saygili U, Gol M, Koyuncuoglu M, Uslu T, Erten O, Ciftci B, Biri A, Bozkurt N, Karabacak O, Himmetoglu O, Amir JN, Nouri M, Hascalik S, Celik O, Parlakpinar H, Mizrak B, Ozsahin M, Önder C, Gezginc K, Colakoglu M, Demir SC, Cetin MT, Kadayifci O, Güzel AB, Polat I, Yildirim G, Özdemir A, Tekirdag AI, Kizkin S, Engin-Ustun Y, Ustun Y, Ozcan C, Serbest S, Ozisik HI, Ergenoglu M, Goker ENT, Uckuyu A, Ozcimen EE, Nisanoglu O, Onal C, Akgun S, Koc S, Cebi Z, Sönmez S, Yasar L, Küpelioglu L, Bilecan S, Aygün M, Zebitay AG, Dursun P, Ötegen Ü, Bozdag G, Yarali H, Demirci F, Mun S, Eraydin E, Sadik S, Sipahi C, Bayol Ü, Sarikaya S, Garipoglu DE, Delilbasi L, Gursoy R, Engin-Ustun Y, Meydanli MM, Atmaca R, Kafkasli A, Canda MT, Kucuk M, Bagriyanik HA, Ozyurt D, Canda T, Güven MA, Tamsoy S, Kaymak O, Ozkale D, Okyay RE, Neslihanoglu R, Mollamahmutoglu L, Basaran A, Gultekin M, Saygili YE, Esinler I, Bayer U, Gunalp S, Aksu T, Gultekin M, Leventerler H, Taga S, Cetin T, Solmaz S, Dikmen N, Karalök H, Ilter E, Tufekci C, Yilmaz S, Karalök AE, Batur O, Kilicdag E, Haydardedeoglu B, Tarim E, Api M, Gültekin E, Görgen H, Cetin A, Yayla M, Özkilic T, Arikan I, Abali R, Arikan D, Bozkurt S, Demir B, Gunalp S, Erden AC, Özcan J, Yazicioglu F, Demirbas R. Endocrinology and reproductive medicine. Arch Gynecol Obstet 2005. [DOI: 10.1007/bf02954773] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
7
|
Sutherland P. Use of a carotid arterial line during organ harvest. Anaesthesia 2000; 55:1226. [PMID: 11121952 DOI: 10.1046/j.1365-2044.2000.01798-19.x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Affiliation(s)
- P Sutherland
- Southampton General Hospital, Southampton SO16 6YD, UK
| |
Collapse
|
8
|
|
9
|
Stec JJ, Silbershatz H, Tofler GH, Matheney TH, Sutherland P, Lipinska I, Massaro JM, Wilson PF, Muller JE, D'Agostino RB. Association of fibrinogen with cardiovascular risk factors and cardiovascular disease in the Framingham Offspring Population. Circulation 2000; 102:1634-8. [PMID: 11015340 DOI: 10.1161/01.cir.102.14.1634] [Citation(s) in RCA: 189] [Impact Index Per Article: 7.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/12/2023]
Abstract
BACKGROUND Fibrinogen has been identified as an independent risk factor for cardiovascular disease and associated with traditional cardiovascular risk factors. Also, the role of elevated fibrinogen in thrombosis suggests that it may be on the causal pathway for certain risk factors to exert their effect. These associations remain incompletely characterized. Moreover, the optimal fibrinogen assay for risk stratification is uncertain. METHODS AND RESULTS In 2632 subjects from cycle 5 of the Framingham Offspring Population, fibrinogen levels were determined with a newly developed immunoprecipitation test (American Biogenetic Sciences) and the functional Clauss method. With the immunoprecipitation method, there were significant linear trends across fibrinogen tertiles (P:<0.001) for age, body mass index, smoking, diabetes mellitus, total cholesterol, HDL cholesterol, and triglycerides in men and women. The Clauss method had significant results (P:<0.030), except for triglycerides in men. Fibrinogen levels were higher for those with compared with those without cardiovascular disease. After covariate adjustment, fibrinogen remained significantly higher in those with cardiovascular disease with the use of the immunoprecipitation test (P:=0.035 and P:=0.018 for men and women, respectively) but not with the Clauss method. CONCLUSIONS Fibrinogen was associated with traditional cardiovascular risk factors. Elevation of fibrinogen may provide a mechanism for risk factors to exert their effect. Also, fibrinogen levels were higher among subjects with cardiovascular disease compared with those without disease. The immunoprecipitation test showed a stronger association with cardiovascular disease than the Clauss method, suggesting that it may be a useful screening tool to identify individuals at increased thrombotic risk.
Collapse
Affiliation(s)
- J J Stec
- Institute for Prevention of Cardiovascular Disease, Cardiovascular Division, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA
| | | | | | | | | | | | | | | | | | | |
Collapse
|
10
|
Lough TJ, Netzler NE, Emerson SJ, Sutherland P, Carr F, Beck DL, Lucas WJ, Forster RL. Cell-to-cell movement of potexviruses: evidence for a ribonucleoprotein complex involving the coat protein and first triple gene block protein. Mol Plant Microbe Interact 2000; 13:962-74. [PMID: 10975653 DOI: 10.1094/mpmi.2000.13.9.962] [Citation(s) in RCA: 102] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/19/2023]
Abstract
The triple gene block proteins (TGBp1-3) and coat protein (CP) of potexviruses are required for cell-to-cell movement. Separate models have been proposed for intercellular movement of two of these viruses, transport of intact virions, or a ribonucleoprotein complex (RNP) comprising genomic RNA, TGBp1, and the CP. At issue therefore, is the form(s) in which RNA transport occurs and the roles of TGBp1-3 and the CP in movement. Evidence is presented that, based on microprojectile bombardment studies, TGBp1 and the CP, but not TGBp2 or TGBp3, are co-translocated between cells with viral RNA. In addition, cell-to-cell movement and encapsidation functions of the CP were shown to be separable, and the rate-limiting factor of potexvirus movement was shown not to be virion accumulation, but rather, the presence of TGBp1-3 and the CP in the infected cell. These findings are consistent with a common mode of transport for potexviruses, involving a non-virion RNP, and show that TGBp1 is the movement protein, whereas TGBp2 and TGBp3 are either involved in intracellular transport or interact with the cellular machinery/docking sites at the plasmodesmata.
Collapse
Affiliation(s)
- T J Lough
- Horticulture and Food Research Institute of New Zealand, Plant Health and Development Group, Auckland.
| | | | | | | | | | | | | | | |
Collapse
|
11
|
Jones DA, Sutherland P. Emergency repair of incidentally diagnosed ascending aortic aneurysm immediately after caesarean section. Br J Anaesth 2000; 84:539. [PMID: 10823116 DOI: 10.1093/oxfordjournals.bja.a013490] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
12
|
Sutherland P, Hallett I, Redgwell R, Benhamou N, MacRae E. Localization of Cell Wall Polysaccharides during Kiwifruit (Actinidia deliciosa) Ripening. Int J Plant Sci 1999; 160:1099-1109. [PMID: 10568777 DOI: 10.1086/314196] [Citation(s) in RCA: 19] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/23/2023]
Abstract
The localization of pectin, cellulose, xyloglucan, and callose was compared in kiwifruit (Actinidia deliciosa [A. Chev.] C. F. Liang and A. R. Ferguson var. deliciosa "Hayward") at harvest, at the end of the first phase of softening, and when ripe. Pectin was visualized using three different methods: labeling of galacturonic acid residues, labeling of negatively charged groups, and labeling with JIM 5 (nonesterified residues) and JIM 7 (methyl-esterified) monoclonal antibodies. Labeling of pectin gave different results depending on the detection system used. Differences related to patterns of change during ripening and to spatial distribution of label intensity. Cell wall pectin was available for labeling at all stages of fruit softening, but no clear differentiation of the middle lamella region was seen, although JIM 5 binding predominated where the middle lamellae joined the intercellular spaces in unripe fruit. Negatively charged groups (cationic gold labeling) and, to a lesser extent, galacturonic acid residues (Aplysia depilans gonad lectin labeling) were preferentially located near the cell wall/plasma membrane boundary. The lack of strong binding of the JIM antibodies indicated that the reactive groups were inaccessible. Cellulose remained intact and labeled densely across the wall at all stages of fruit ripening. Distribution of xyloglucan was patchy at harvest but was scattered throughout the wall later in ripening. Alterations to labeling of xyloglucan indicated that some epitopes were differentially exposed. Plasmodesmatal regions were clearly different in composition to other wall areas, showing an absence of cellulose labeling, specific pectin labeling, and callose presence. A similar predominance of pectin labeling compared with cellulose also occurred at the middle lamella wedge near intercellular spaces.
Collapse
|
13
|
Abstract
One of the main aims of palliative care is to enable clients to receive and access services in a way that maximizes their choice in relation to where, when and how they receive care. To achieve this end, it is essential that statutory and voluntary care agencies collaborate to provide an effective range of services. This article offers for consideration the experience of a children's hospice service and a paediatric oncology outreach service who collaborated to provide a service for children requiring paediatric and terminal care. It identifies a number of elements which are important for positive and effective collaboration.
Collapse
Affiliation(s)
- M Farrell
- Department of Nursing, University of Liverpool/Alder Hey Royal, Liverpool Children's NHS Trust
| | | |
Collapse
|
14
|
Kirk EA, Sutherland P, Wang SA, Chait A, LeBoeuf RC. Dietary isoflavones reduce plasma cholesterol and atherosclerosis in C57BL/6 mice but not LDL receptor-deficient mice. J Nutr 1998; 128:954-9. [PMID: 9614153 DOI: 10.1093/jn/128.6.954] [Citation(s) in RCA: 138] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Susceptibility to atherosclerosis is determined by a combination of genetic and environmental factors, including diet. Consumption of diets rich in soy protein has been claimed to protect against the development of atherosclerosis. Potential mechanisms include cholesterol lowering, inhibition of lipoprotein oxidation and inhibition of cell proliferation by soy proteins or isoflavones, such as genistein, that are present in soy. This study was designed to determine whether soy isoflavones confer protection against atherosclerosis in mice and whether they reduce serum cholesterol levels and lipoprotein oxidation. C57BL/6 and LDL receptor-deficient (LDLr-null) mice were fed soy protein-based, high fat diets with isoflavones present (IF+, 20.85 g/100 g protein, 0.027 g/100 g genistein, 0.009 g/100 g daidzein) or diets from which isoflavones, and possibly other components, had been extracted (IF-, 20.0 g/100 g protein, 0.002 g/100 g genistein, 0.001 g/100 g daidzein). Because LDLr-null mice develop extensive atherosclerosis and hypercholesterolemia after minimal time on a high fat diet, they were fed the diets for 6 wk, whereas C57BL/6 mice were fed the diets for 10 wk. Plasma cholesterol levels did not differ between LDLr-null mice fed IF- and those fed IF+, but were 30% lower in C57BL/6 mice fed the IF+ diet than in those fed the IF- diet. Susceptibility of LDL to oxidative modification, measured as the lag phase of conjugated diene formation in LDLr-null mice, was not altered by isoflavone consumption. All LDLr-null mice developed atherosclerosis, and the presence or deficiency of dietary isoflavones did not influence atherosclerotic lesion area. In contrast, atherosclerotic lesion area was significantly reduced in C57BL/6 mice fed IF+ compared with those fed IF-. Thus, this study demonstrates that although the isoflavone-containing diet resulted in a reduction in cholesterol levels in C57BL/6 mice, it had no effect on cholesterol levels or on susceptibility of LDL to oxidative modification in LDLr-null mice. Further, dietary isoflavones did not protect against the development of atherosclerosis in LDLr-null mice but did decrease atherosclerosis in C57BL/6 mice. These findings suggest that soy isoflavones might lower cholesterol levels by increasing LDL receptor activity, and the reduction in cholesterol may offer some protection against atherosclerosis.
Collapse
Affiliation(s)
- E A Kirk
- Department of Medicine and the Nutritional Sciences Program, University of Washington, Seattle, WA 98195, USA
| | | | | | | | | |
Collapse
|
15
|
Lipinska I, Feng D, Wilson P, Mittleman M, Muller J, Sutherland P, Silbershatz H, D'Agostino R, Levy D, Tofler G. Variability and associations of fibrinogen and C-reactive protein in the Framingham offspring study. J Am Coll Cardiol 1998. [DOI: 10.1016/s0735-1097(98)81278-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
16
|
Wu W, Cook ME, Chu FS, Buttles T, Hunger J, Sutherland P. Case study of bovine dermatitis caused by oat straw infected with Fusarium sporotrichioides. Vet Rec 1997; 140:399-400. [PMID: 9141223 DOI: 10.1136/vr.140.15.399] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Abstract
A dermatitis characterised by discrete, raised, plaque-like and cracked skin lesions of variable sizes on the udder, the hind quarters, the lips and muzzle of all the cows in a herd was suspected of being caused by the oat straw used in bedding, after initial feed analysis and skin culture were negative for toxins and dermatophytes. Mycological analysis indicated an extensive infestation of the oat straw by Fusarium sporotrichioides, a toxic mould, and an immunochemical assay indicated dermatotoxic trichothecenes in the straw (0.22 microgram/g dried straw). An ethyl acetate extract of the straw induced a necrotic response on shaved rat skin. Ingestion of the toxic bedding straw and inhalation of toxic straw dust probably also caused the internal haemorrhage and lung emphysema observed in the two cows that died. The regression of the dermatitis and the recovery of general herd health after the withdrawal of the oat straw further supported the diagnosis.
Collapse
Affiliation(s)
- W Wu
- Department of Poultry Science, University of Wisconsin, Madison 53706, USA
| | | | | | | | | | | |
Collapse
|
17
|
Bostom AG, Shemin D, Lapane KL, Sutherland P, Nadeau MR, Wilson PW, Yoburn D, Bausserman L, Tofler G, Jacques PF, Selhub J, Rosenberg IH. Hyperhomocysteinemia, hyperfibrinogenemia, and lipoprotein (a) excess in maintenance dialysis patients: a matched case-control study. Atherosclerosis 1996; 125:91-101. [PMID: 8831931 DOI: 10.1016/0021-9150(96)05865-0] [Citation(s) in RCA: 75] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
Abstract
Maintenance dialysis patients experience an exceedingly high incidence of arteriosclerotic cardiovascular disease (CVD) events that are poorly predicted by traditional CVD risk factor indices. We evaluated the prevalence of three non-traditional CVD risk factors, i.e. hyperhomocysteinemia, hyperfibrinogenemia, and lipoprotein (a) Lp(a)) excess, and combined hyperhomocysteinemia, hyperfibrinogenemia, and Lp(a) excess, in maintenance dialysis patients. Fasting total plasma homocysteine (Hcy), fibrinogen, Lp(a), glucose, and total and HDL cholesterol levels, and traditional CVD risk factor (i.e. glucose tolerance, smoking, hypertension, dyslipidemia) prevalences were assessed in 71 dialysis patients and 71 age, sex, and race matched Framingham Study controls free of clinical renal disease, with normal serum creatinine (< or = 1.5 mg/dl). Mean plasma Hcy 23.7 vs. 9.9 microM, P = 0.0001), fibrinogen (457 vs. 309 mg/dl, P = 0.0001), and Lp(a) (30 vs. 17 mg/dl, P = 0.0070) levels were substantially increased in the dialysis patients. Matched odds ratios (with 95% confidence intervals), dialysis patients/controls, for hyperhomocysteinemia, hyperfibrinogenemia, and Lp(a) excess, alone or combined, were markedly greater in the dialysis patients, with no evidence of confounding by the traditional CVD risk factors: hyperhomocysteinemia, 105.0 (29.9-368.9); hyperfibrinogenemia, 16.6 (6.6-42.0); Lp(a) excess, 3.5 (1.5-8.4); all three combined 35.0 (5.7-199.8). Given in vitro evidence that Hcy, Lp(a), and fibrinogen interact to promote atherothrombosis, combined hyperhomocysteinemia, hyperfibrinogenemia, and Lp(a) excess may contribute to the high incidence of vascular disease sequelae experienced by dialysis patients, which is inadequately explained by traditional CVD risk factors. Controlled, prospective studies of well-characterized maintenance dialysis cohorts are urgently required to substantiate this hypothesis.
Collapse
Affiliation(s)
- A G Bostom
- Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts New England Medical Center, Boston, MA 02111, USA
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
18
|
Hammond E, Sutherland P. Variation in study leave funding amongst anaesthetic trainees. Anaesthesia 1996. [DOI: 10.1111/j.1365-2044.1996.tb07863.x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
19
|
Bostom AG, Shemin D, Lapane KL, Nadeau MR, Sutherland P, Chan J, Rozen R, Yoburn D, Jacques PF, Selhub J, Rosenberg IH. Folate status is the major determinant of fasting total plasma homocysteine levels in maintenance dialysis patients. Atherosclerosis 1996; 123:193-202. [PMID: 8782850 DOI: 10.1016/0021-9150(96)05809-1] [Citation(s) in RCA: 81] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
Abstract
Limited data are available on the determinants of homocysteinemia or the association between plasma homocysteine (Hcy) levels and prevalent cardiovascular disease (CVD) in maintenance dialysis patients. We assessed etiology of renal failure, residual renal function and dialysis adequacy-related variables, and vitamin status, as determinants of fasting total plasma homocysteine (Hcy) in 75 maintenance dialysis patients. We also assessed the potential interactive effect on plasma Hcy of folate status and a common mutation (ala to val; homozygous val-val frequency approximately 10%) in methylenetetrahydrofolate reductase (MTHFR), a folate-dependent enzyme crucial for the remethylation of homocysteine (Hcy) to methionine. Lastly, we evaluated whether the Hcy levels differed amongst these patients in the presence or absence of prevalent CVD, after adjustment for the traditional CVD risk factors. Fasting total plasma Hcy, folate, pyridoxal 5'-phosphate (PLP; active B6), B12, creatinine, glucose, total and HDL cholesterol levels, and presence of the ala to val MTHFR mutation were determined, and clinical CVD and CVD risk factor prevalence were ascertained. General linear modelling/analysis of covariance revealed: (1) folate status and serum creatinine were the only significant independent predictors of fasting Hcy; (2) there was a significant interaction between presence of the val mutation and folate status, i.e., among patients with plasma folate below the median (< 29.2 ng/ml), geometric mean Hcy levels were 33% greater (29.0 vs. 21.8 microM, P = 0.012) in the pooled homozygotes (val-val) and heterozygotes (ala-val) for the ala to val mutation, vs. normals (ala-ala); (3) there was no association between prevalent CVD and plasma Hcy. Given potentially intractable survivorship effects, prospective cohort studies will be required to clarify the relationship between plasma Hcy or any putative CVD risk factor, and incident CVD in dialysis patients. If a positive association between plasma Hcy and incident CVD can be established in maintenance dialysis patients, the current data provide a rationale for additional folic acid supplementation in this patient population.
Collapse
Affiliation(s)
- A G Bostom
- Vitamin Bioavailability Laboratory, Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts New England Medical Center, Boston MA 02111, USA
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
20
|
Bostom AG, Roubenoff R, Dellaripa P, Nadeau MR, Sutherland P, Wilson PW, Jacques PF, Selhub J, Rosenberg IH. Validation of abbreviated oral methionine-loading test. Clin Chem 1995; 41:948-9. [PMID: 7768022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Grants] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023]
|
21
|
Bostom AG, Roubenoff R, Dellaripa P, Nadeau MR, Sutherland P, Wilson PW, Jacques PF, Selhub J, Rosenberg IH. Validation of abbreviated oral methionine-loading test. Clin Chem 1995. [DOI: 10.1093/clinchem/41.6.948] [Citation(s) in RCA: 29] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
|
22
|
Bostom AG, Shemin D, Lapane KL, Miller JW, Sutherland P, Nadeau M, Seyoum E, Hartman W, Prior R, Wilson PW. Hyperhomocysteinemia and traditional cardiovascular disease risk factors in end-stage renal disease patients on dialysis: a case-control study. Atherosclerosis 1995; 114:93-103. [PMID: 7605381 DOI: 10.1016/0021-9150(94)05470-4] [Citation(s) in RCA: 124] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
Abstract
Hyperhomocysteinemia occurs frequently in end-stage renal disease (ESRD), but its prevalence in comparison with traditional cardiovascular disease (CVD) risk factors is unknown. Fasting total plasma homocysteine, potential determinants of plasma homocysteine (i.e., plasma B-vitamins and serine), total and HDL cholesterol, glucose, and creatinine, were determined in 24 ESRD patients on dialysis, and 24 age, gender, and race matched Framingham Offspring Study controls with normal renal function. Presence of clinical CVD and CVD risk factors was established by standardized methods. Mean plasma homocysteine was markedly higher in the ESRD patients versus controls (22.7 vs. 9.5 mumol/l). ESRD patients were 33 times more likely than controls to have hyperhomocysteinemia (> 15.8 mumol/l) (95% confidence interval, 5.7-189.6). Hyperhomocysteinemia persisted in the ESRD patients despite normal to supernormal B-vitamin status. Plasma serine levels below the tenth percentile of the control distribution were found in 75% of the ESRD patients. Oral serine supplementation caused a 37% increase in mean plasma serine, but had no effect on plasma homocysteine in four ESRD patients with supernormal plasma folate, low plasma serine, and hyperhomocysteinemia. Given its unusually high prevalence, improved management of hyperhomocysteinemia might reduce CVD sequelae in ESRD.
Collapse
Affiliation(s)
- A G Bostom
- Framingham Heart Study, Epidemiology and Biometry Program, MA 01701, USA
| | | | | | | | | | | | | | | | | | | |
Collapse
|
23
|
Gebara OC, Mittleman MA, Sutherland P, Lipinska I, Matheney T, Xu P, Welty FK, Wilson PW, Levy D, Muller JE. Association between increased estrogen status and increased fibrinolytic potential in the Framingham Offspring Study. Circulation 1995; 91:1952-8. [PMID: 7895352 DOI: 10.1161/01.cir.91.7.1952] [Citation(s) in RCA: 186] [Impact Index Per Article: 6.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/27/2023]
Abstract
BACKGROUND Although extensive evidence indicates that estrogen is responsible for the markedly decreased cardiovascular risk of premenopausal women, the mechanism through which estrogen might exert its protective effect has not been adequately explained. Since thrombosis is now recognized to play an important role in the onset of cardiovascular disease, we investigated the relation between estrogen status and fibrinolytic potential, a determinant of thrombotic risk. METHODS AND RESULTS We determined levels of plasminogen activator inhibitor (PAI-1) antigen and tissue plasminogen activator (TPA) antigen in 1431 subjects from the Framingham Offspring Study. Fibrinolytic potential was compared between subjects with high estrogen status (premenopausal women and postmenopausal women receiving hormone replacement therapy) and low estrogen status (men and postmenopausal women not receiving hormone replacement therapy). In all comparisons, subjects with high estrogen status had greater fibrinolytic potential (lower PAI-1 levels) than subjects with low estrogen status. First, postmenopausal women receiving estrogen replacement therapy had lower levels of PAI-1 than those not receiving therapy (13.0 +/- 0.5 versus 19.5 +/- 1.0 ng/mL, P < .001). Second, premenopausal women had lower levels of PAI-1 than men of a similar age (14.8 +/- 0.6 versus 20.3 +/- 0.8 ng/mL, P < .001); this sex difference diminished when postmenopausal women not receiving hormone replacement therapy were compared with men of a similar age (19.6 +/- 0.7 versus 21.1 +/- 0.7 ng/mL, P = .089). Third, premenopausal women had markedly lower levels of PAI-1 antigen than postmenopausal women not receiving estrogen therapy (14.8 +/- 0.6 versus 19.5 +/- 1.0 ng/mL, P < .001). The between-group differences observed for TPA antigen were similar to those for PAI-1 antigen. CONCLUSIONS Each of these comparisons indicates that the cardioprotective effect of estrogen may be mediated, in part, by an increase in fibrinolytic potential. These findings might provide at least a partial explanation for the protection against cardiovascular disease experienced by premenopausal women, and the loss of that protection following menopause.
Collapse
Affiliation(s)
- O C Gebara
- Institute for Prevention of Cardiovascular Disease, Deaconess Hospital, Boston, Mass 02215
| | | | | | | | | | | | | | | | | | | |
Collapse
|
24
|
Abstract
Therapist sexual misconduct has its genesis in the therapeutic relationship. The mental health professions have long recognized the delicacy with which the therapist must handle the therapeutic relationship, with its power imbalance, inherent vulnerability of the patient, and transference and countertransference reactions. The prevention of sexual contact starts with the careful attention to boundary violations, which, though themselves perhaps not harmful, may escalate into sexualized behavior. Methods of preventing this behavior include the establishment of clear guidelines for practitioners and the expansion of the educational process for therapists, therapists' employers, patients, and other professionals. Last resorts lie in the legal and quasi-legal proceedings available to victims, such as civil suits for damages, criminal complaints, board of licensing complaints, and actions before professional associations. The best method of preventing sexual contact with patients involves respecting the boundaries of the professional relationship and avoidance of the slippery slope.
Collapse
|
25
|
Lu M, Dubé I, Raimondi S, Carroll A, Zhao Y, Minden M, Sutherland P. Molecular characterization of the t(10;14) translocation breakpoints in T-cell acute lymphoblastic leukemia: further evidence for illegitimate physiological recombination. Genes Chromosomes Cancer 1990; 2:217-22. [PMID: 2078512 DOI: 10.1002/gcc.2870020309] [Citation(s) in RCA: 22] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022] Open
Abstract
The t(10;14)(q24;q11) translocation is a non-random chromosome change seen in the leukemic cells of 5-10% of patients with T-cell acute lymphoblastic leukemia (T-ALL). Recent studies support the hypothesis that the translocation occurs in the course of aberrant physiological recombination and results in the juxtaposition of a T-cell receptor (TCR) gene in 14q11 with a putative oncogene, TCL3, in 10q24. We cloned and sequenced the translocation breakpoints on both derivative 10q+ and 14q- chromosomes from a patient with t(10;14)(q24;q11) T-ALL. Two distinct diversity segments of TCRD, D delta 2 and D delta 3, were identified at the two translocation breakpoints on chromosome 14. The 9.5 kb DNA that separates these two subunits in the germline was deleted, possibly in the course of a D-D joining event. The two chromosome 10 breakpoints were 10 nucleotides apart and occurred in the immediate vicinity of a pseudo-heptamer signal motif. N-region addition is also evident at the breakpoint on the derivative chromosome 10. Our observations strongly suggest that the IG/TCR recombinase normally involved in V-(D)-J joining was involved in the process of the t(10;14)(q24;q11) translocation.
Collapse
MESH Headings
- Base Sequence
- Blotting, Southern
- Chromosome Banding
- Chromosome Deletion
- Chromosomes, Human, Pair 10
- Chromosomes, Human, Pair 14
- Cloning, Molecular
- DNA, Neoplasm/genetics
- DNA, Neoplasm/isolation & purification
- Genomic Library
- Humans
- Hybrid Cells/cytology
- Leukemia-Lymphoma, Adult T-Cell/genetics
- Molecular Sequence Data
- Recombination, Genetic
- Restriction Mapping
- Translocation, Genetic
Collapse
Affiliation(s)
- M Lu
- University of Toronto Hospitals Cancer Cytogenetics Program, Ontario, Canada
| | | | | | | | | | | | | |
Collapse
|
26
|
Gallus A, Murphy W, Nacey J, Morris M, Sutherland P, Marshall V, Magnani H. The influence of Org 10172, an antithrombotic heparinoid, on urinary blood loss after transurethral prostatectomy. Thromb Res 1989; 56:229-38. [PMID: 2482549 DOI: 10.1016/0049-3848(89)90165-5] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
We have measured the effects of Org 10172 (a mixture of naturally occurring glycosaminoglycans derived from hog intestinal mucosa) on blood loss after transurethral prostatectomy (TURP), using doses which are likely to prevent postoperative venous thrombosis (VT). 48 patients entered a double-blind randomised pilot study: 18 were given subcutaneous (sc) injections of a placebo and 30 received sc Org 10172 (750 anti-Xa units/day, 500 units twice daily (bid), or 750 units bid, starting just before TURP and continued until discharge; 10 patients per group). No Org 10172 regimen increased peroperative blood loss but all caused a similar trend towards increased urinary bleeding after surgery. Since there was no apparent dose effect gradient, it was decided to pool the data from all three dosing blocks: this analysis showed that Org 10172 increased geometric mean blood loss during the first 2 days after surgery from 10.4 gm hemoglobin (Hgb; range = 3.2-71) to 20.5 gm Hgb (range = 1.9-147) (p = .005), an effect which retained its significance after allowing for two other major determinants of postoperative bleeding, the weight of prostate resected and the length of surgery, and also when pooling was restricted to the twice daily Org 10172 injection groups and their corresponding controls. Bleeding was not severe, but our results indicate a need for caution when considering the use of Org 10172 in this setting.
Collapse
Affiliation(s)
- A Gallus
- Department of Hematology, Flinders Medical Centre, Bedford Park, South Australia
| | | | | | | | | | | | | |
Collapse
|
27
|
Thompson LM, Sutherland P, Steffan JS, McAlister-Henn L. Gene sequence and primary structure of mitochondrial malate dehydrogenase from Saccharomyces cerevisiae. Biochemistry 1988; 27:8393-400. [PMID: 3072021 DOI: 10.1021/bi00422a015] [Citation(s) in RCA: 49] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
Abstract
The nucleotide sequence was determined for a 1.5-kilobase genomic fragment containing the mitochondrial malate dehydrogenase gene (MDH1) of Saccharomyces cerevisiae. The open-reading frame encodes a precursor form of the mature enzyme containing an amino-terminal extension of 17 amino acid residues. In vitro translation experiments confirm that the initial translation product of MDH1 is larger than the mature polypeptide. Transcription of MDH1 initiates at several sites from 83 to 97 nucleotides 5' of the translational start site. Alignment of the amino acid sequence for the mature yeast enzyme with those for mammalian mitochondrial and for Escherichia coli malate dehydrogenases reveals polypeptides of very similar sizes with identical amino acids at 54% and 48% of the residue positions, respectively. The amino acid sequences of the yeast and mammalian mitochondrial targeting sequences are similar but less related than the mature polypeptides. The yeast MDH1 gene is shown to reside on chromosome XI.
Collapse
Affiliation(s)
- L M Thompson
- Department of Biological Chemistry, California College of Medicine, University of California, Irvine 92717
| | | | | | | |
Collapse
|
28
|
Ellwood DA, Sutherland P, Kent C, O'Connor M. Maternal narcotic addiction: pregnancy outcome in patients managed by a specialized drug-dependency antenatal clinic. Aust N Z J Obstet Gynaecol 1987; 27:92-8. [PMID: 3675451 DOI: 10.1111/j.1479-828x.1987.tb00952.x] [Citation(s) in RCA: 36] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/06/2023]
Abstract
A retrospective analysis has been made of the outcome of pregnancy in 174 women abusing narcotics, managed by a specialist team from a drug-dependency antenatal clinic. These women were cared for through 182 pregnancies of greater than 20 weeks' gestation, resulting in 183 live and 5 stillbirths. The majority of patients were enrolled in a methadone programme and stabilized on the drug before the third trimester. The group was characterized by a high prevalence of previous obstetric and medical problems. The most common antenatal complications were preterm labour (24%) and anaemia (12%). Preterm delivery and small-for-gestational-age each occurred in a quarter of pregnancies. The mean birth-weight for the group was 2,746 g +/- 721 g; mean +/- S.D. Eight perinatal deaths occurred (5 stillbirths, 3 neonatal deaths), giving a perinatal mortality rate of 43/1,000. The data on narcotic abusers have been compared with similar data obtained from randomly selected public antenatal clinic patients who delivered during the same period.
Collapse
Affiliation(s)
- D A Ellwood
- Division of Obstetrics and Gynaecology, King George V Memorial Hospital for Mothers and Babies, Sydney
| | | | | | | |
Collapse
|
29
|
Stocks J, Nöthen U, Sutherland P, Hatch D, Helms P. Improved accuracy of the occlusion technique for assessing total respiratory compliance in infants. Pediatr Pulmonol 1987; 3:71-7. [PMID: 3588059 DOI: 10.1002/ppul.1950030206] [Citation(s) in RCA: 38] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/06/2023]
Abstract
The occlusion technique to measure total respiratory system compliance (Cocc) was used in 28 sedated infants with a variety of cardiopulmonary diseases and 14 anaesthetised infants during the first 2 years of life. In this report, we describe some of the potential problems in the technique and how to avoid them. Invalidation of the occlusion technique because of consistent failure to relax during brief airway occlusions occurred in only four of 42 infants despite the fact that only four infants were studied during the first month of life and 17 were between 12 and 26 months old. The technique was invalidated in two intubated infants because of persistent leaks around the endotracheal tube. In the remaining 36 infants, data sometimes had to be excluded as a result of instability and end-expiratory volume, intermittent leaks, or failure to relax during occlusions performed at low lung volumes or during inspiration. However, by performing 15-25 occlusions per infant, it was possible to obtain sufficient reliable data for accurate analysis of Cocc in all these infants. Providing that the potential errors and limitations of the occlusion technique are recognized, it appears to be applicable to a wide range of healthy and sick infants.
Collapse
|
30
|
Abstract
The fungus Aspergillus may cause a variety of pulmonary disorders as a result of its ability to act as an allergen, as a simple saprophyte or as an infectious organism. The clinical manifestations range from hypersensitivity syndromes, in which corticosteroid therapy may be indicated, to disseminated infections, in which corticosteroid agents may be causative. The diagnosis may not be immediately apparent. Six cases are presented to illustrate the sometimes confusing manifestations of the disease.
Collapse
|
31
|
Andley UP, Sutherland P, Liang JN, Chakrabarti B. Changes in tertiary structure of calf-lens alpha-crystallin by near-UV irradiation: role of hydrogen peroxide. Photochem Photobiol 1984; 40:343-9. [PMID: 6484003 DOI: 10.1111/j.1751-1097.1984.tb04597.x] [Citation(s) in RCA: 70] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/20/2023]
|
32
|
|